P48.05 Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC?Miguel García-Pardo, G. Liu, Khaleeq Khan et al.|Journal of Thoracic Oncology|2021Cited by 3